An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories

Background  Laboratories screening for blood‐borne virus infections in blood and blood products are required by international standards and guidelines to ensure that their testing processes remain within control. An effective means of ensuring this aim is through participation in a quality control p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vox sanguinis 2009-11, Vol.97 (4), p.309-316
Hauptverfasser: Walker, S., Dimech, W., Kiely, P., Smeh, K., Francis, B., Karakaltsas, M., Dax, E. M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 316
container_issue 4
container_start_page 309
container_title Vox sanguinis
container_volume 97
creator Walker, S.
Dimech, W.
Kiely, P.
Smeh, K.
Francis, B.
Karakaltsas, M.
Dax, E. M.
description Background  Laboratories screening for blood‐borne virus infections in blood and blood products are required by international standards and guidelines to ensure that their testing processes remain within control. An effective means of ensuring this aim is through participation in a quality control programme. Analyses of results from a quality control (QC) programme conducted for the Abbott PRISM (PRISM) assays are reported. Materials and methods  Laboratories participating in the National Serology Reference Laboratory, Australia's PRISM QC programme were provided with aliquots of a multimarker QC sample which were tested regularly in each PRISM subchannel. Test results were submitted to a single database using an Internet‐based QC monitoring system, EDCNet. The QC test results submitted between 15 October 2001 and 5 March 2006 for each PRISM instrument and each lot of PRISM reagent were analysed to determine the imprecision and bias in each test system. Results  A total of 157 404 test results from approximately 47 000 test runs submitted into the EDCNet database were analysed. Six batches of the multimarker QC samples were tested in 454 PRISM reagent lots. The coefficient of variation of QC sample test results ranged from 9·17 to 15·83%, 8·29 to 9·44%, 10·50 to 15·38% and 7·05 to 10·32% when tested in the PRISM anti‐hepatitis C virus, anti‐human immunodeficiency virus, anti‐human T‐cell lymphotrophic virus and hepatitis B surface antigen assays, respectively. Analysis of QC test results reported from testing in the anti‐HTLV assay detected one lot of reagent (10572HN00) which was identified to be an outlier using Tukey's filter. Discussion  Analysis of test results of an external QC sample can be used as a statistical process control through ongoing measurement of imprecision. When laboratories test the same QC sample in the same assay and submit test results to a single database, the results can be compared and a measure of bias can be calculated. The resulting QC programme can offer detection of unexpected variation in the testing processes and the source of variation investigated.
doi_str_mv 10.1111/j.1423-0410.2009.01218.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_745689217</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1878659781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4658-5c532e792823a6b4fc314e2b7cfb19898b2b0ce23377dec51b27174b359c33143</originalsourceid><addsrcrecordid>eNqNkc1vFCEYxonR2LX6LxjixdOsfM0ABw9Nq7VJbf22NwIMq6wMtDCju1f_chl3UxMvygXy8nuePHkfACBGS1zPs_USM0IbxOqAICSXCBMslps7YHH7cRcsEGKkkQjxA_CglDVCSBDR3gcHWHaCUCYX4OdRhD6OLkc9-hR1gDeTDn7cQpvimFOA1zl9yXoYHFylDN-8O3v_GtqvbvBhGnx0xbo4Qj8MU0y6FL0t1Q-akFIPi8vfvXVQx34_qWb9ZEcYtElZjyl7Vx6Ceysdinu0vw_Bx5cvPhy_as4vT8-Oj84by7pWNK1tKXFckppcd4atLMXMEcPtymAppDDEIOsIpZz3zrbYEI45M7SVllaUHoKnO98a4mZyZVSDr-lD0NGlqSjO2k5Igvm_ScqQbAmfPZ_8Ra7TVHcZiiLzghkSskJiB9mcSslupa6zH3TeKozU3Kdaq7k2Ndem5j7V7z7Vpkof7_0nM7j-j3BfYAWe74AfPrjtfxurT5dX86vqm53el9FtbvU6f1Mdp7xVny9O1UV3ddKd8LcK01_Ekb6h</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223494089</pqid></control><display><type>article</type><title>An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Walker, S. ; Dimech, W. ; Kiely, P. ; Smeh, K. ; Francis, B. ; Karakaltsas, M. ; Dax, E. M.</creator><creatorcontrib>Walker, S. ; Dimech, W. ; Kiely, P. ; Smeh, K. ; Francis, B. ; Karakaltsas, M. ; Dax, E. M.</creatorcontrib><description>Background  Laboratories screening for blood‐borne virus infections in blood and blood products are required by international standards and guidelines to ensure that their testing processes remain within control. An effective means of ensuring this aim is through participation in a quality control programme. Analyses of results from a quality control (QC) programme conducted for the Abbott PRISM (PRISM) assays are reported. Materials and methods  Laboratories participating in the National Serology Reference Laboratory, Australia's PRISM QC programme were provided with aliquots of a multimarker QC sample which were tested regularly in each PRISM subchannel. Test results were submitted to a single database using an Internet‐based QC monitoring system, EDCNet. The QC test results submitted between 15 October 2001 and 5 March 2006 for each PRISM instrument and each lot of PRISM reagent were analysed to determine the imprecision and bias in each test system. Results  A total of 157 404 test results from approximately 47 000 test runs submitted into the EDCNet database were analysed. Six batches of the multimarker QC samples were tested in 454 PRISM reagent lots. The coefficient of variation of QC sample test results ranged from 9·17 to 15·83%, 8·29 to 9·44%, 10·50 to 15·38% and 7·05 to 10·32% when tested in the PRISM anti‐hepatitis C virus, anti‐human immunodeficiency virus, anti‐human T‐cell lymphotrophic virus and hepatitis B surface antigen assays, respectively. Analysis of QC test results reported from testing in the anti‐HTLV assay detected one lot of reagent (10572HN00) which was identified to be an outlier using Tukey's filter. Discussion  Analysis of test results of an external QC sample can be used as a statistical process control through ongoing measurement of imprecision. When laboratories test the same QC sample in the same assay and submit test results to a single database, the results can be compared and a measure of bias can be calculated. The resulting QC programme can offer detection of unexpected variation in the testing processes and the source of variation investigated.</description><identifier>ISSN: 0042-9007</identifier><identifier>EISSN: 1423-0410</identifier><identifier>DOI: 10.1111/j.1423-0410.2009.01218.x</identifier><identifier>PMID: 19682349</identifier><identifier>CODEN: VOSAAD</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>bias ; Blood Donors ; Blood products ; Blood-Borne Pathogens ; blood-borne virus screening ; Donor Selection - methods ; Donor Selection - standards ; EDCNet ; Female ; Humans ; Immunoassay ; imprecision ; Infections ; Male ; Medical laboratories ; Practice Guidelines as Topic ; PRISM ; Quality Control ; Safety Management ; Virus Diseases - blood ; Virus Diseases - prevention &amp; control</subject><ispartof>Vox sanguinis, 2009-11, Vol.97 (4), p.309-316</ispartof><rights>2009 St Vincent's Institute. Journal compilation © 2009 International Society of Blood Transfusion</rights><rights>2009 International Society of Blood Transfusion</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4658-5c532e792823a6b4fc314e2b7cfb19898b2b0ce23377dec51b27174b359c33143</citedby><cites>FETCH-LOGICAL-c4658-5c532e792823a6b4fc314e2b7cfb19898b2b0ce23377dec51b27174b359c33143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1423-0410.2009.01218.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1423-0410.2009.01218.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19682349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walker, S.</creatorcontrib><creatorcontrib>Dimech, W.</creatorcontrib><creatorcontrib>Kiely, P.</creatorcontrib><creatorcontrib>Smeh, K.</creatorcontrib><creatorcontrib>Francis, B.</creatorcontrib><creatorcontrib>Karakaltsas, M.</creatorcontrib><creatorcontrib>Dax, E. M.</creatorcontrib><title>An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories</title><title>Vox sanguinis</title><addtitle>Vox Sang</addtitle><description>Background  Laboratories screening for blood‐borne virus infections in blood and blood products are required by international standards and guidelines to ensure that their testing processes remain within control. An effective means of ensuring this aim is through participation in a quality control programme. Analyses of results from a quality control (QC) programme conducted for the Abbott PRISM (PRISM) assays are reported. Materials and methods  Laboratories participating in the National Serology Reference Laboratory, Australia's PRISM QC programme were provided with aliquots of a multimarker QC sample which were tested regularly in each PRISM subchannel. Test results were submitted to a single database using an Internet‐based QC monitoring system, EDCNet. The QC test results submitted between 15 October 2001 and 5 March 2006 for each PRISM instrument and each lot of PRISM reagent were analysed to determine the imprecision and bias in each test system. Results  A total of 157 404 test results from approximately 47 000 test runs submitted into the EDCNet database were analysed. Six batches of the multimarker QC samples were tested in 454 PRISM reagent lots. The coefficient of variation of QC sample test results ranged from 9·17 to 15·83%, 8·29 to 9·44%, 10·50 to 15·38% and 7·05 to 10·32% when tested in the PRISM anti‐hepatitis C virus, anti‐human immunodeficiency virus, anti‐human T‐cell lymphotrophic virus and hepatitis B surface antigen assays, respectively. Analysis of QC test results reported from testing in the anti‐HTLV assay detected one lot of reagent (10572HN00) which was identified to be an outlier using Tukey's filter. Discussion  Analysis of test results of an external QC sample can be used as a statistical process control through ongoing measurement of imprecision. When laboratories test the same QC sample in the same assay and submit test results to a single database, the results can be compared and a measure of bias can be calculated. The resulting QC programme can offer detection of unexpected variation in the testing processes and the source of variation investigated.</description><subject>bias</subject><subject>Blood Donors</subject><subject>Blood products</subject><subject>Blood-Borne Pathogens</subject><subject>blood-borne virus screening</subject><subject>Donor Selection - methods</subject><subject>Donor Selection - standards</subject><subject>EDCNet</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoassay</subject><subject>imprecision</subject><subject>Infections</subject><subject>Male</subject><subject>Medical laboratories</subject><subject>Practice Guidelines as Topic</subject><subject>PRISM</subject><subject>Quality Control</subject><subject>Safety Management</subject><subject>Virus Diseases - blood</subject><subject>Virus Diseases - prevention &amp; control</subject><issn>0042-9007</issn><issn>1423-0410</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1vFCEYxonR2LX6LxjixdOsfM0ABw9Nq7VJbf22NwIMq6wMtDCju1f_chl3UxMvygXy8nuePHkfACBGS1zPs_USM0IbxOqAICSXCBMslps7YHH7cRcsEGKkkQjxA_CglDVCSBDR3gcHWHaCUCYX4OdRhD6OLkc9-hR1gDeTDn7cQpvimFOA1zl9yXoYHFylDN-8O3v_GtqvbvBhGnx0xbo4Qj8MU0y6FL0t1Q-akFIPi8vfvXVQx34_qWb9ZEcYtElZjyl7Vx6Ceysdinu0vw_Bx5cvPhy_as4vT8-Oj84by7pWNK1tKXFckppcd4atLMXMEcPtymAppDDEIOsIpZz3zrbYEI45M7SVllaUHoKnO98a4mZyZVSDr-lD0NGlqSjO2k5Igvm_ScqQbAmfPZ_8Ra7TVHcZiiLzghkSskJiB9mcSslupa6zH3TeKozU3Kdaq7k2Ndem5j7V7z7Vpkof7_0nM7j-j3BfYAWe74AfPrjtfxurT5dX86vqm53el9FtbvU6f1Mdp7xVny9O1UV3ddKd8LcK01_Ekb6h</recordid><startdate>200911</startdate><enddate>200911</enddate><creator>Walker, S.</creator><creator>Dimech, W.</creator><creator>Kiely, P.</creator><creator>Smeh, K.</creator><creator>Francis, B.</creator><creator>Karakaltsas, M.</creator><creator>Dax, E. M.</creator><general>Blackwell Publishing Ltd</general><general>S. Karger AG</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7TM</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>200911</creationdate><title>An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories</title><author>Walker, S. ; Dimech, W. ; Kiely, P. ; Smeh, K. ; Francis, B. ; Karakaltsas, M. ; Dax, E. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4658-5c532e792823a6b4fc314e2b7cfb19898b2b0ce23377dec51b27174b359c33143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>bias</topic><topic>Blood Donors</topic><topic>Blood products</topic><topic>Blood-Borne Pathogens</topic><topic>blood-borne virus screening</topic><topic>Donor Selection - methods</topic><topic>Donor Selection - standards</topic><topic>EDCNet</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoassay</topic><topic>imprecision</topic><topic>Infections</topic><topic>Male</topic><topic>Medical laboratories</topic><topic>Practice Guidelines as Topic</topic><topic>PRISM</topic><topic>Quality Control</topic><topic>Safety Management</topic><topic>Virus Diseases - blood</topic><topic>Virus Diseases - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walker, S.</creatorcontrib><creatorcontrib>Dimech, W.</creatorcontrib><creatorcontrib>Kiely, P.</creatorcontrib><creatorcontrib>Smeh, K.</creatorcontrib><creatorcontrib>Francis, B.</creatorcontrib><creatorcontrib>Karakaltsas, M.</creatorcontrib><creatorcontrib>Dax, E. M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Vox sanguinis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walker, S.</au><au>Dimech, W.</au><au>Kiely, P.</au><au>Smeh, K.</au><au>Francis, B.</au><au>Karakaltsas, M.</au><au>Dax, E. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories</atitle><jtitle>Vox sanguinis</jtitle><addtitle>Vox Sang</addtitle><date>2009-11</date><risdate>2009</risdate><volume>97</volume><issue>4</issue><spage>309</spage><epage>316</epage><pages>309-316</pages><issn>0042-9007</issn><eissn>1423-0410</eissn><coden>VOSAAD</coden><abstract>Background  Laboratories screening for blood‐borne virus infections in blood and blood products are required by international standards and guidelines to ensure that their testing processes remain within control. An effective means of ensuring this aim is through participation in a quality control programme. Analyses of results from a quality control (QC) programme conducted for the Abbott PRISM (PRISM) assays are reported. Materials and methods  Laboratories participating in the National Serology Reference Laboratory, Australia's PRISM QC programme were provided with aliquots of a multimarker QC sample which were tested regularly in each PRISM subchannel. Test results were submitted to a single database using an Internet‐based QC monitoring system, EDCNet. The QC test results submitted between 15 October 2001 and 5 March 2006 for each PRISM instrument and each lot of PRISM reagent were analysed to determine the imprecision and bias in each test system. Results  A total of 157 404 test results from approximately 47 000 test runs submitted into the EDCNet database were analysed. Six batches of the multimarker QC samples were tested in 454 PRISM reagent lots. The coefficient of variation of QC sample test results ranged from 9·17 to 15·83%, 8·29 to 9·44%, 10·50 to 15·38% and 7·05 to 10·32% when tested in the PRISM anti‐hepatitis C virus, anti‐human immunodeficiency virus, anti‐human T‐cell lymphotrophic virus and hepatitis B surface antigen assays, respectively. Analysis of QC test results reported from testing in the anti‐HTLV assay detected one lot of reagent (10572HN00) which was identified to be an outlier using Tukey's filter. Discussion  Analysis of test results of an external QC sample can be used as a statistical process control through ongoing measurement of imprecision. When laboratories test the same QC sample in the same assay and submit test results to a single database, the results can be compared and a measure of bias can be calculated. The resulting QC programme can offer detection of unexpected variation in the testing processes and the source of variation investigated.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19682349</pmid><doi>10.1111/j.1423-0410.2009.01218.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0042-9007
ispartof Vox sanguinis, 2009-11, Vol.97 (4), p.309-316
issn 0042-9007
1423-0410
language eng
recordid cdi_proquest_miscellaneous_745689217
source MEDLINE; Access via Wiley Online Library
subjects bias
Blood Donors
Blood products
Blood-Borne Pathogens
blood-borne virus screening
Donor Selection - methods
Donor Selection - standards
EDCNet
Female
Humans
Immunoassay
imprecision
Infections
Male
Medical laboratories
Practice Guidelines as Topic
PRISM
Quality Control
Safety Management
Virus Diseases - blood
Virus Diseases - prevention & control
title An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T20%3A30%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20international%20quality%20control%20programme%20for%20PRISM%20chemiluminescent%20immunoassays%20in%20blood%20service%20and%20blood%20product%20laboratories&rft.jtitle=Vox%20sanguinis&rft.au=Walker,%20S.&rft.date=2009-11&rft.volume=97&rft.issue=4&rft.spage=309&rft.epage=316&rft.pages=309-316&rft.issn=0042-9007&rft.eissn=1423-0410&rft.coden=VOSAAD&rft_id=info:doi/10.1111/j.1423-0410.2009.01218.x&rft_dat=%3Cproquest_cross%3E1878659781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223494089&rft_id=info:pmid/19682349&rfr_iscdi=true